SS18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62947433324234E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.13273843030493E-12 |
Normal-vs-Stage2 |
3.72090003253334E-09 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.62525548574877E-12 |
Stage1-vs-Stage2 |
6.671600E-01 |
Stage1-vs-Stage3 |
2.684400E-03 |
Stage1-vs-Stage4 |
9.324200E-03 |
Stage2-vs-Stage3 |
1.979360E-01 |
Stage2-vs-Stage4 |
2.216400E-01 |
Stage3-vs-Stage4 |
9.802400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62703184258817E-12 |
Normal-vs-AfricanAmerican |
2.96370039620797E-10 |
Normal-vs-Asian |
2.435600E-02 |
Caucasian-vs-AfricanAmerican |
1.841570E-01 |
Caucasian-vs-Asian |
2.646400E-01 |
AfricanAmerican-vs-Asian |
5.357400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.33066907387547E-16 |
Normal-vs-Female |
3.04012370833107E-12 |
Male-vs-Female |
3.619600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.00739980193987E-10 |
Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
Normal-vs-Age(61-80Yrs) |
9.99200722162641E-16 |
Normal-vs-Age(81-100Yrs) |
4.79499999994637E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.000000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.416000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.665800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.321420E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.452600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.577000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.238050E-02 |
Normal-vs-Grade 2 |
2.02060590481778E-14 |
Normal-vs-Grade 3 |
1.11022302462516E-16 |
Normal-vs-Grade 4 |
1.11022302462516E-16 |
Grade 1-vs-Grade 2 |
2.655800E-01 |
Grade 1-vs-Grade 3 |
5.579300E-03 |
Grade 1-vs-Grade 4 |
1.317910E-03 |
Grade 2-vs-Grade 3 |
3.224700E-04 |
Grade 2-vs-Grade 4 |
7.75280000000489E-05 |
Grade 3-vs-Grade 4 |
2.231000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.01989527934165E-11 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
1.115590E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
4.2027E-05 |
N0-vs-N1 |
9.808400E-01 |
|
|